Cencora.
US drug wholesale company company
- Reports this week
- 1
- Active events
- 1
- Connections
- 100
What's happening
Active this week
Earlier this month
-
Cencora filed required disclosures regarding institutional ownership changes with the SEC and received analyst reports from Morgan Stanley.Well supported3 reports
-
MarketBeat reported analyst recommendations for healthcare companies Hims & Hers Health and Cencora.Some support1 report
-
Trump's tariff plan caused market tanking, an event that occurred on August 22, 2025.Some support11 reports3 developments inside
-
Exagen Inc. was listed on the Nasdaq stock exchange, and Cencora was listed on the NYSE stock exchange, both on September 1, 2026.Some support2 reports
-
Acquisition integration between Cencora and OneOncology boosted gross profit margins.Some support1 report
-
Market comparison of two large-cap healthcare companies, Cencora and Cigna Group, is underway.Some support1 report
One to three months ago
-
Cencora, a company, sources and distributes products in the US and is headquartered in Conshohocken, PA.Some support1 report
-
Jim Cramer praised a company regarding its outlook, noting that customer concentration presents operational vulnerability, and acquisitions are expanding at-home medical supply footprints.Some support1 report
-
Institutional investor reduced holdings in Cencora stock by 11.5% and filed required disclosures with the SEC.Some support1 report
-
Investment firms initiated coverage and adjusted holdings in companies including Cencora and United Bank, involving the State of North Carolina and William Blair.Well supported3 reports
-
Cencora filed required disclosures with the Securities and Exchange Commission on July 18, 2026.Some support2 reports1 development inside
-
Bryn Mawr Trust Advisors LLC bought a new stake in Cencora shares and filed a 13F with the SEC.Some support1 report
-
JPMorgan Chase raised its price target on Cencora on August 14, 2026.Some support2 reports
-
Bank of America provided a rating report on Cencora, which is being tracked by MarketBeat.Some support2 reports
-
Cencora is identified as a wholesale distributor for AbbVie, while both AbbVie and Abbott Laboratories are noted as healthcare industry leaders.Some support4 reports
-
Eva Boratto has been appointed as the Chief Financial Officer for Cencora.Some support1 report
-
Cencora is providing wraparound services for biosimilars. An MSOs platform includes RCA for physician attraction. The pending MWI Animal Health merger adds EPS headwind.Some support2 reports
-
Quarterly results drove a stock price increase for Cor and Cencora.Some support1 report
Gone quiet
No new reports in 90+ days-
An investor made multiple stock purchases in companies including Cencora, Gilead Sciences, GE Aerospace, and American Express.Some support1 report
-
Market comparison of two medical companies, Cencora and Ryman Healthcare, is underway.Some support1 report
-
Amgen is concentrating revenue through a pharmaceutical wholesaler, which is either Cencora or Cardinal Health.Some support7 reports
-
Cencora filed disclosures with the SEC regarding institutional holdings on June 16, 2026.Some support1 report
-
Cencora's stock price fell due to poor financial results.Some support1 report
-
Cencora's role in the opioid crisis was documented on August 18, 2025, involving the Centers for Disease Control and Prevention.Some support1 report
-
Cencora's lower equity earnings impacted Walgreens Boots Alliance's adjusted operating income, and its CEO commented on US sales weakness.Speculative1 report1 development inside
-
Strategic partnerships between Walgreens Boots Alliance and Cencora provide a stable revenue base.Some support2 reports
-
Cencora must survive the impact of Trump's tariffs.Some support1 report
-
Kadant, News Corp, Cencora, and Royalty Pharma were identified as high-quality stocks operating in the pharmaceutical industry.Speculative1 report
-
Cencora appointed Mark Durcan as Chairman of the Board, while Steven H. Collis served as CEO and Chairman.Some support3 reports
-
Oscar Health and Cencora are identified as health insurance providers.Speculative1 report
-
Waters Corporation and Cencora announced a strategic collaboration to build a diagnostics leader.Some support1 report1 development inside
-
New over-the-counter Continuous Glucose Monitoring (CGM) availability marks a new era for Cencora's products.Speculative1 report
-
Cencora expanded its capabilities through a distribution services agreement with Citius Oncology.Some support1 report
-
Cencora supported the pharmacy industry through ThoughtSpot during an event held in Las Vegas.Some support1 report
-
Teladoc and Cencora are identified as US drug wholesale and healthcare companies.Some support2 reports
-
Cencora and CVS Health are identified as health insurance providers, with Generative AI noted as an industry disruptor.Some support2 reports
-
GLP-1 class products are cited as the driver of company growth for Cencora.Some support1 report
-
Cencora and McKesson Corporation both raised their annual profit forecasts, and it was noted that McKesson is headquartered in Texas.Some support1 report
-
Lisa Gill and Elizabeth Anderson questioned Cencora regarding growth moderation and RCA integration in August 2025.Some support2 reports
-
Both Aetna and Cencora operate within the healthcare distribution and insurance sector.Some support1 report
-
Zacks Investment Research provided stock analysis and ratings for Cencora on September 1, 2025.Some support2 reports
-
Cencora and Climb Bio, Inc. are both outperforming their respective medical peers.Some support1 report
-
Cencora, GE Aerospace, and Howmet Aerospace were listed as GARP stocks on August 28, 2025.Some support1 report1 development inside
-
Cencora and Medpace were analyzed for value investment on August 28, 2025, with Cencora receiving a superior Value grade (A) over Medpace (D).Some support1 report
-
Cencora's stock outperformed the general market index (S&P 500) on September 5, 2025.Some support3 reports
-
Cencora and PACS Group, two companies operating in the medical sector, provide senior care and assisted living facilities in the US and are subject to market comparison.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Cencora this week
News at the entities that move Cencora most-
AbbVie StructuralKori Wallace was appointed vice president at AbbVie.Moves Cencora
-
Amgen StructuralLaurus Labs is shifting focus from building to filling capacity and may participate in Amgen's supply chain.Moves Cencora
-
Securities and Exchange Commission StructuralHester Peirce's resignation reduced the number of SEC commissioners, while Paul Atkins serves as Chairman and Mark Uyeda is a sitting commissioner.Moves Cencora
-
Morgan Stanley TransactionalMorgan Stanley maintained an Overweight rating on Amazon and raised its price target, while Nvidia GPUs are expected to be deployed by AWS.Moves Cencora
-
Cardinal Health OperationalJPMorgan Chase adjusted its price target for Cardinal Health on July 1, 2025.Moves Cencora
-
National Pension Service StructuralAsia equity manager David Chung is associated with the National Pension Service and Samsung Electronics.Moves Cencora
Connections
The 40 strongest of 100, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Eva Boratto Structural
Eva Boratto serves as the Chief Financial Officer of Cencora.
-
AbbVie Structural
AbbVie utilizes Cencora as a wholesale partner to distribute a concentrated portion of its U.S. sales market.
-
Amgen Structural
Amgen relies on Cencora as a critical distributor and wholesaler for its pharmaceutical products.
-
SEC Structural
Cencora must file disclosures with the SEC regarding institutional holdings, indicating a mandatory regulatory dependency.
-
Steven H. Collis Structural
Steven H. Collis served as CEO and Chairman of Cencora and was involved in share transactions.
-
Securities and Exchange Commission Structural
Cencora is required to file disclosures and comply with regulations set by the Securities and Exchange Commission.
-
Cardinal Health Operational
Both companies are leading pharmaceutical wholesalers operating in direct competition within the US market.
-
National Pension Service Structural
NPS holds a growing investment stake in Cencora, creating a financial dependency.
Show all 40 connections
-
Walgreens Operational
The companies maintain a strategic partnership and contract relationship providing a stable revenue base.
-
McKesson Corporation Operational
The companies are viewed as direct competitors in the healthcare market, evidenced by shared market outlooks and industry classifications.
-
Elizabeth Campbell Transactional
Elizabeth Campbell sold company stock in Cencora.
-
Nvidia Operational
The relationship is characterized by competitive market presence and shared exposure to generative AI trends and market signals.
-
Morgan Stanley Transactional
Morgan Stanley's analyst reports and price target reviews influence Cencora's market valuation.
-
Royal Bank of Canada Mentioned together
Royal Bank of Canada has provided financial coverage and sector ratings on Cencora.
-
Cor Structural
Cor is identified as the key individual or representative associated with the company Cencora.
-
Hims & Hers Health Operational
Cencora and Hims & Hers Health are actively competing for investment within the healthcare sector.
-
CVS Health Operational
Cencora and CVS Health are active competitors within the health insurance providers segment.
-
Medpace Operational
Both companies are analyzed and compared as competitors in the value investment market.
-
Chicago Shared context
The company operates within the geographical context of the city, where related professional services are also located.
-
Citigroup Mentioned together
Citigroup provided market analysis and buy ratings on Cencora shares.
-
Leerink partners Mentioned together
Leerink partners raised its target price for Cencora stock.
-
Elizabeth Campbell Transactional
EVP Elizabeth Campbell sold company stock in Cencora.
-
Bank of America Mentioned together
Bank of America issued a rating report concerning Cencora.
-
Baltimore Shared context
Cencora is involved in ongoing legal challenges with the city of Baltimore.
-
Jim Cramer Mentioned together
Jim Cramer mentioned Cencora alongside other companies in a financial discussion.
-
Los Angeles Shared context
same place or sector
-
MarketBeat Mentioned together
MarketBeat reports financial data, including consensus ratings and analyst recommendations, for Cencora.
-
Ryman Healthcare Mentioned together
The two medical companies were mentioned together in a market comparison.
-
Conshohocken Shared context
Cencora is headquartered in the municipality of Conshohocken, Pennsylvania.
-
United Bank Transactional
United Bank increased its share holdings in Cencora on August 25, 2026.
-
Nasdaq Shared context
Cencora is a publicly traded company operating within the stock exchange market.
-
Paris Shared context
same place or sector
-
State of North Carolina Transactional
The State of North Carolina acquired shares in Cencora through purchases made on behalf of the state.
-
Medical Shared context
Cencora is identified as operating within the Medical sector and group.
-
Celanese Corporation Mentioned together
Both companies are characterized as large firms operating within the industrial and materials sectors.
-
Washington Trust Bank Transactional
Washington Trust Bank reduced its stock holdings in Cencora by 11.5%.
-
RCA Mentioned together
Cencora's sector is noted to benefit from RCA's performance.
-
London Shared context
Cencora operates within the geographic context of London.
-
Tel Aviv Mentioned together
No evidence was provided linking Tel Aviv to Cencora; the available evidence concerned a law firm office location in Tel Aviv.
-
New York City Shared context
The evidence provided describes Cencora's financial performance but does not establish any coupling or specific relationship with New York City.
History
Events by the month they beganOctober 2026
2 eventsSeptember 2026
5 events- Exagen Inc. was listed on the Nasdaq stock exchange, and Cencora was listed on the NYSE stock exchange, both on September 1, 2026.
- Acquisition integration between Cencora and OneOncology boosted gross profit margins.
- Market comparison of two large-cap healthcare companies, Cencora and Cigna Group, is underway.
- Cencora, a company, sources and distributes products in the US and is headquartered in Conshohocken, PA.
- Jim Cramer praised a company regarding its outlook, noting that customer concentration presents operational vulnerability, and acquisitions are expanding at-home medical supply footprints.
August 2026
8 events- Institutional investor reduced holdings in Cencora stock by 11.5% and filed required disclosures with the SEC.
- Bryn Mawr Trust Advisors LLC bought a new stake in Cencora shares and filed a 13F with the SEC.
- JPMorgan Chase raised its price target on Cencora on August 14, 2026.
- Bank of America provided a rating report on Cencora, which is being tracked by MarketBeat.
- Cencora is identified as a wholesale distributor for AbbVie, while both AbbVie and Abbott Laboratories are noted as healthcare industry leaders.
- Eva Boratto has been appointed as the Chief Financial Officer for Cencora.
- Cencora is providing wraparound services for biosimilars. An MSOs platform includes RCA for physician attraction. The pending MWI Animal Health merger adds EPS headwind.
- Quarterly results drove a stock price increase for Cor and Cencora.
Show 2 earlier months
July 2026
2 eventsJune 2026
30 events- Cencora filed required disclosures regarding institutional ownership changes with the SEC and received analyst reports from Morgan Stanley.
- Trump's tariff plan caused market tanking, an event that occurred on August 22, 2025.
- Investment firms initiated coverage and adjusted holdings in companies including Cencora and United Bank, involving the State of North Carolina and William Blair.
- Market comparison of two medical companies, Cencora and Ryman Healthcare, is underway.
- Amgen is concentrating revenue through a pharmaceutical wholesaler, which is either Cencora or Cardinal Health.
- Cencora filed disclosures with the SEC regarding institutional holdings on June 16, 2026.
- Cencora's stock price fell due to poor financial results.
- Cencora's role in the opioid crisis was documented on August 18, 2025, involving the Centers for Disease Control and Prevention.
- Cencora's lower equity earnings impacted Walgreens Boots Alliance's adjusted operating income, and its CEO commented on US sales weakness.
- Strategic partnerships between Walgreens Boots Alliance and Cencora provide a stable revenue base.
- Cencora must survive the impact of Trump's tariffs.
- Kadant, News Corp, Cencora, and Royalty Pharma were identified as high-quality stocks operating in the pharmaceutical industry.
- Cencora appointed Mark Durcan as Chairman of the Board, while Steven H. Collis served as CEO and Chairman.
- Oscar Health and Cencora are identified as health insurance providers.
- Waters Corporation and Cencora announced a strategic collaboration to build a diagnostics leader.
- New over-the-counter Continuous Glucose Monitoring (CGM) availability marks a new era for Cencora's products.
- Cencora expanded its capabilities through a distribution services agreement with Citius Oncology.
- Cencora supported the pharmacy industry through ThoughtSpot during an event held in Las Vegas.
- Teladoc and Cencora are identified as US drug wholesale and healthcare companies.
- Cencora and CVS Health are identified as health insurance providers, with Generative AI noted as an industry disruptor.
- GLP-1 class products are cited as the driver of company growth for Cencora.
- Cencora and McKesson Corporation both raised their annual profit forecasts, and it was noted that McKesson is headquartered in Texas.
- Lisa Gill and Elizabeth Anderson questioned Cencora regarding growth moderation and RCA integration in August 2025.
- Both Aetna and Cencora operate within the healthcare distribution and insurance sector.
- Zacks Investment Research provided stock analysis and ratings for Cencora on September 1, 2025.
- Cencora and Climb Bio, Inc. are both outperforming their respective medical peers.
- Cencora, GE Aerospace, and Howmet Aerospace were listed as GARP stocks on August 28, 2025.
- Cencora and Medpace were analyzed for value investment on August 28, 2025, with Cencora receiving a superior Value grade (A) over Medpace (D).
- Cencora's stock outperformed the general market index (S&P 500) on September 5, 2025.
- Cencora and PACS Group, two companies operating in the medical sector, provide senior care and assisted living facilities in the US and are subject to market comparison.